Samir Rashmikant Patel Akari Therapeutics PLC (AKTX) insider trading activity

Samir Rashmikant Patel is of Akari Therapeutics Plc. Currently has a direct ownership of 91.4 Million shares of AKTX, which is worth approximately $91.4 Million. The most recent transaction as insider was on Jun 30, 2024, when has been sold 91,396,000 shares (Ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).